CRISPR Therapeutics AG
CRSP
Market Cap$5.34B
Close$
$-32.54
156.1% downside
Current Fair Value
156.1% downsideOvervalued by 156.1% based on the discounted cash flow analysis.
Share Statistics
| Market cap | $5.34 Billion |
|---|---|
| Enterprise Value | $3.65 Billion |
| Dividend Yield | $0.0 (0.0%) |
| Earnings per Share | $-1.94 |
| Beta | 0.0 |
| Outstanding Shares | 84,883,091 |
| Avg 30 Day Volume | 1,336,254 |
Return
| Return on Equity | - |
|---|---|
| Return on Assets | - |
| Return on Invested Capital | - |
Valuation & Multiples
| P/E Ratio | -34.76 |
|---|---|
| PEG | 19.23 |
| Price to Sales | 14.49 |
| Price to Book Ratio | 2.63 |
| Enterprise Value to Revenue | 9.82 |
| Enterprise Value to EBIT | -16.39 |
| Enterprise Value to Net Income | -24 |
| Total Debt to Enterprise | 0 |
| Debt to Equity | 0 |
Revenue Sources
No data
ESG Score
No data
About CRISPR Therapeutics AG
CEO: Samarth Kulkarni